Cantatore-Francis, Julie L; Cohen-Pfeffer, Jessica; Balwani, Manisha et al. (2010) Hepatoerythropoietic porphyria misdiagnosed as child abuse: cutaneous, arthritic, and hematologic manifestations in siblings with a novel UROD mutation. Arch Dermatol 146:529-33
|
Khanna, Richie; Soska, Rebecca; Lun, Yi et al. (2010) The pharmacological chaperone 1-deoxygalactonojirimycin reduces tissue globotriaosylceramide levels in a mouse model of Fabry disease. Mol Ther 18:23-33
|
Schiffmann, Raphael; Warnock, David G; Banikazemi, Maryam et al. (2009) Fabry disease: progression of nephropathy, and prevalence of cardiac and cerebrovascular events before enzyme replacement therapy. Nephrol Dial Transplant 24:2102-11
|
Hwu, Wuh-Liang; Chien, Yin-Hsiu; Lee, Ni-Chung et al. (2009) Newborn screening for Fabry disease in Taiwan reveals a high incidence of the later-onset GLA mutation c.936+919G>A (IVS4+919G>A). Hum Mutat 30:1397-405
|
Banikazemi, Maryam; Bultas, Jan; Waldek, Stephen et al. (2007) Agalsidase-beta therapy for advanced Fabry disease: a randomized trial. Ann Intern Med 146:77-86
|
Grace, Marie E; Balwani, Manisha; Nazarenko, Irina et al. (2007) Type 1 Gaucher disease: null and hypomorphic novel chitotriosidase mutations-implications for diagnosis and therapeutic monitoring. Hum Mutat 28:866-73
|
Laradi, S; Tukel, T; Khediri, S et al. (2006) Mucopolysaccharidosis type IV: N-acetylgalactosamine-6-sulfatase mutations in Tunisian patients. Mol Genet Metab 87:213-8
|
Nance, Christopher S; Klein, Christopher J; Banikazemi, Maryam et al. (2006) Later-onset Fabry disease: an adult variant presenting with the cramp-fasciculation syndrome. Arch Neurol 63:453-7
|
Desnick, Robert J; Banikazemi, Maryam (2006) Fabry disease: clinical spectrum and evidence-based enzyme replacement therapy. Nephrol Ther 2 Suppl 2:S172-85
|
Spada, Marco; Pagliardini, Severo; Yasuda, Makiko et al. (2006) High incidence of later-onset fabry disease revealed by newborn screening. Am J Hum Genet 79:31-40
|
Showing the most recent 10 out of 73 publications